Abstract
The prevalence of obesity and diabetes is epidemic. Severe insulin resistance (defined as the need for ≥ 200 units of insulin per day to achieve glycemic control) is commonly seen with obesity and can complicate diabetes management. The management of patients with diabetes who have severe insulin resistance is difficult, and at times frustrating, and requires a multifaceted approach. Weight loss is the best treatment option, which can be a challenging task for patients to achieve and maintain. Medications that decrease insulin needs like metformin, thiazolidinediones, or pramlintide may help, but some patients also need high doses of insulin. This article reviews these different treatment options and provides practical advice on weight loss, use of insulin sensitizers, and use of U-500 insulin.
| Original language | English |
|---|---|
| Pages (from-to) | 163-171 |
| Number of pages | 9 |
| Journal | Postgraduate Medicine |
| Volume | 122 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Insulin resistance
- Insulin sensitizers
- U-500 insulin
- Weight loss
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Managing highly insulin-resistant diabetes mellitus: Weight loss approaches and medical management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver